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I . INTRODUCTION
Programs for interplanetary missions such as Voyager, require sterile flight
vehicles if they will enter the atmosphere or land on the surface of extra-
terrestrial planets. Twobasic concepts have been proposed for the achieve-
ment of the sterility of the spacecraft. These are called "Terminal Steri-
lization" and "Assembly/Sterilizer" processing.
Terminal sterilization refers to the concept in which a vehicle is assembled
and checked out in a clean room, decontaminated with a gaseous biocidal
agent (ETO), sealed in a cannister, and then exposed to dry heat steriliza-
tion. Subsequent to sterilization no access to the flight vehicle is possible
without recontamination.
The Assembly/Sterilizer concept was developed by GEand was first presented to
NASAin the Mariner B and Voyager system design studies in 1963. The Assembly/
Sterilizer is an ultra-bioclean-room facility which allows decontamination
and sterilization of a disassembled spacecraft, and subsequent assembly, check-
out, adjustment, and if necessary, repair of the spacecraft in a sterile
environment. All humanoperators are topologically and biologically isolated
from the spacecraft after sterilization operations have been initiated.
A study program to investigate the feasibility of the Assembly/Sterilizer
concept was started by GEon 21 July 1965 under contract to the Langley
Research Center of the National Aeronautics and SpaceAdministration. The
contract was completed on 21 February 1967.
The results of the investigation indicate that the Assembly/Sterilizer concept
is feasible.
A. Program Objectives
The objective was to provide the initial demonstration of the Technical
feasibility of a facility which would permit the decontamination and sterili-
zation of spacecraft. Envisioned also, was the further capability for
subsequent checkout, adjustment, repair, and encapsulation of the payload in
a biological barrier under sterile conditions. An analog of an Assembly/
Sterilizer facility was prepared which could accomplish these objectives
without the necessity of erecting a large facility. Concurrent with this
program, a design study was initiated to incorporate the results of the tests
in progress into a facility plan which would reflect the knowledge acquired
during this program.
B. Program Ground Rules
The program as prescribed in Appendix A was divided into four tasks which,
it was felt, would give the widest possible scope to the study. They were:
I o
2.
3.
4.
Test Sample
Test Program and Demonstration
Bio-assay
Full Scale Facility Design Study
An effort was madeto ensure that the test sample used in this program
would be representative of prime hardware commonlyused throughout the
aerospace industry. The sample, during assembly, was of sufficient complexity
that its assembly created somedifficulties for the operator chosen to work
on it. The parts making up the assembled component, after withstanding
decontamination and sterilization procedure, were required to function flaw-
lessly.
Little was known concerning the physical limitations of personnel who would
be required to work in a facility of this type. Further knowledge was
desirable also from a standpoint of personnel reactions to specific problems
introduced at various increments in the program.
It also became necessary, early in the program, to investigate the ability
of available tools to withstand sterilization requirements. The tools
selected were those necessary for completion of the task assigned and not of
every type and variety available. The test program as initiated was designed
to assure that the analog after installation was achieving the required
decontamination and sterilization objectives. This portion of the program
was divided into 3 parts.
Sterilization Verification
Manipulation
Feasibility Demonstration
The first part was necessary to verify that the chambers were achieving the
required goals using the prescribed treatments. The second part involved the
performance of assigned tasks under progressively more restrictive conditions,
and the third part consists of simulating actual assembly under various
conditions, thereby assuring the capability of the analog.
To carry out the above assignments, and in so-doing meet the necessary
sterilization criteria, it was necessary to perform biological assays on
samples located in the analog. Since component parts and normal atmosphere
contain a variable amount of viable organisms, a portion of the test program
consisted of introducing known numbers of viable organisms into the chambers
and, after prescribed treatments, conducting a bio-assay to determine the
survival rate. A large quantity of sterility control specimens were prepared
in the laboratory and used during the test program.
The final task, as envisioned, was to use the information as gathered to
assist in the design stages of the full scale facility study. A number of
plans were considered throughout the test program, but after due deliberation
and comparison, the number under consideration was reduced and a more detailed
study ensued. The plan selected is described in detail in Appendix E.
C. Summary of Conclusions
The collected data encompassing all the tasks set forth in this program,
and described in greater detail herein, demonstrated the feasibility of the
Assembly/Sterilizer concept. Present-day aerospace hardware can be assembled
under "clean room" conditions, decontaminated, sterilized, and still perform
its designed function with no loss of response. Human operators, if carefully
selected, can perform fairly complex assembly operations under such conditions
with little discomfort. The tools used in the program were limited only
by their ability to withstand the sterilization cycles. Tools such as
screwdrivers with plastic handles, and those containing moving parts, were
found incompatible with sterilization techniques.
All of the objectives set forth in Appendix A relative to the bio-assay
portion were successfully met. Large microbial populations were reduced
significantly using Ethylene oxide, between three to eight decades in most
cases.
All the cycles performed in the analog were successful, inthat no living
organism could be detected as having survived after assembly, insertion
and/or repair subsequent to sterilization.
II. PROGRAMACTIVITYANDACCOMPLISHMENTS
A. TASKI. TESTSAMPLE
I) DESIGN
In performance of the studies of this contract, it was necessary to perform
demonstration tests consisting of typical sterilization, assembly, checkout,
and packaging operations in the Assembly/Sterilizer Analog and to perform
biological assays to demonstrate the achievement and maintenance of sterility.
To create the greatest realism in these demonstration tests and the most
accurate analog of Full-Scale Assembly/Sterilizer operations, the use _f
actual spacecraft hardware would have been desirable. However, the high
unit cost and the number of componentsrequired for'a meaningful demonstra-
tion would have resulted in excessive test hardware costs. Furthermore,
since qualified dry heat sterilizable componentsare not in the present
inventory of spacecraft hardware, the design and qualification of components
would have represented prohibitive and unjustified expenditure of time and
funding.
A second approach would have been to sterilize and assemble groups of "parts"
of simple geometric shapes madeof stainless steel. Using this sterile
"tinkertoy" approach would have permitted a simplified biological sampling
situation; and if conic forms were used, the test specimens could have been
good visual analogs of spacecraft. However, the resulting specimenswould
not have been any more than visually analogous to any realisti_ spacecraft
equipment, and would have had no useful performance capability.
A compromisewas madebetween the use of qualified spacecraft equipment and
the "tinkertoy" blocks. By designing a simplified test sample componentit
was possible to achieve most of the benefit of either of the above without
being restricted by high cost on the one hand or lack of realism on the
other. It was considered necessary thatthe optimum componentsshould employ
a reasonable range of spacecraft materials, electronic parts, and assembly
techniques, and should be capable of a useful performance function. The
test sample selected was a printed circuit stage mountedon supporting brackets
which are in turn attached to an element of spacecraft skin bonded to heat
shield material.
The test sample, Figure II-I, was fabricated of an aluminum skin, two
inches by four inches by forty thousandths thick to which was bonded a one
quarter inch thick ESMheat shield which contained a thermocouple. Mounted
on this basic structure, by meansof brackets and supports, was an epoxy
glass printed circuit board containing the electronics circuitry which included
transistors, resistors, diodes, and capacitors. The circuit of the test
sample, Figure 11-2, in concurrence with Langley technical representatives, was
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Figure II-I - Test Sample For AssemblylSterilizer(SK-56117-802)
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Figure II-2-Test Sample Circuit
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modified by changing from a one-stage audio amplifier, as originally pro-
prosed, to a triggered multivibrator. This was done in order to present a
more typical hardware-type representative of an unmanned planetary lander.
A test set was required to drive the binary counter of the test sample and
to monitor its response. The test set as illustrated in Figure II-3 consisted
of a signal generator ana an output indicator.
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2) MANUFACTURING
The manufacturing flow diagram of Figure II-4 shows the orderly flow of
materials from receipt of raw materials to final assembly.
Since a large percentage of Lne assembly of a prime interplanetary spacecraft
will be done under class i00 clean room conditions, it was deemed desireable
to assemble _he test sample printed circ_,it boards under class i00 conditions.
Therefore, a class i00 laminar flow bench was employed as the work location
for assembling Lhe test sample printed circuit boards. To determine the
bio-environment in the laminar flow bench, Reynier slit air samplers and
stainless steel fall-out strips were used to monitor the populations of organisms
flowing across the assembly area in the bench, and the organism fallout within
t_,e bench. To provide an indication of the bio-e_vironment improvement provided
by the bench, air samples were taken in the controlled environment area in
which the laminar flow bench was located. The results of the bench and room
assays are reported under Task 3.
Figures 11-5, through 11-7 show the clean bench assembly set-up. Figure 11-5
shows the full bench top with tools, parts, printed circuit holding fixture,
Reynier slit air samplers, and four trays of fall-out strips.
Figure 11-6 shows a closer view of the working area of the bench. The fixture
is holding a partially wired test sample printed circuit board. To the right
of the fixture are the technicians tools. Behind the fixture are two fall-out
strip trays. To the left of the fixture are three plastic bags. The one
closest to the fixture contains a completed board. Next to the completed board
is a bag containing an unwired board, and next to that are the bagged parts for
this board.
Figure 11-7 shows the technician working on the board. He wears a lint free smock
and cap, a surgical mask, and finger cots. The bench and technician are
located in a controlled environment area which is an ante-chamber to the GE
horizontal laminar flow clean room at 3198 Chestnut Street.
Figure 11-8 below, shows two views of a manufacturing prototype of the test
sample. This prototype was used to confirm metal working tooling and shows
the mechanical configuration of the test sample.
Figures ll-9A and 9B are illustrations of the final "Prime test sample. This
sample is one of those used in the demonstration cycles of Task 4.
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Figure  11-5 Class  100 Clean Bench Set-Up 
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Figure 11-7 Assembly of T e s t  Sample Printed 
Circuit Board 
Figure 11-8 Test Sample Manufacturing 
Prototype 
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3) TESTING
To establish the suitability of the test sample for the program, a breadboard
of the circuitry was exposed to one cycle of sterilization, 24 hours at
135 degrees C., followed by a 20 hour operational life test. The procedure
for this test was to perform the following steps.
I. Operate the test sample breakboard and photograph input and output
waveforms on a dual t@aceoscilloscope.
2. Soak test circuit for 24 hours at + 135Oc(non-operating)
3. Repeat step #i.
4. Operate test circuit for 20 hours (accumulated hours of operation)
repeating step #I every two hours.
Monitored oven temperature during the temperature soak period of the test
ranged from 272 to 276°F.
Table ll-I and Figure II-10 show the breadboard and the input and output waveforms
recorded during the test. Both input (sawtooth wave) and output (square
wave) signals were fed into a Tektronix plug-in amplifier Model CAoperated
in the chopped mode. The waveforms were superimposed upon each other for
display on the oscilloscope screen. The amplifier of the dual trace oscil-
loscope used to monitor the input and output waveforms was checked and call-
brated with the Internal calibration of two similar oscilloscopes. The test
sample test set provided the drawing signal and test load for the test
sample.
TABLE II-I
FIGURE TIME IN TEST SCOPE SETTING
Vert. Horlz.
10-b Pre Temp. Soak 2V c_ 0.I sec/cm
10-c Initial Post Temp. Soak 2V/cm 0.I sec/cm
(After 5 minutes operation)
10-d After 4 hours operation 2V/cm 0.i sec/_m
10-e After I0 hours operation 2V/cm 0.I sec/cm
10-f After 20 hours operation 2V/cm 0.I sec/cm
(End of test)
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a .  TEST SAMPLE BREADBOARD 
c. I N I T I A L  POST TEMP. SOAK 
e .  AFTER 10 HOURS OPERATION 
Figure  11-10 Test Sample 
b.  PRE TEMP SOAK 
d.  AFTER 4 HOURS OPERATION 
1 
1 
i 
f .  AFTER 20 HRS. OPER. END OF TEST 
14 E n v i r o n m e n t a l  T o l e r a n c e  T e s t  R e s u l t s  
There were no detectable changes evidenced in either the pulse shapes, signal
levels, or frequency rates of the test circuit waveforms as a result of
being subjected to the specified test.
Following satisfactory completion of the breadboard sample, fifty-six printed
circuit boards representing "Prime" hardware, were assembled, and 55 of
them subsequently operated satisfactorily. The test samples were tested
in accordance with the equipment set up of Figure 4-4 of the test plan
Revision A, 20 January 1966, Appendix B hereto. T_e binary counter was
excited with a saw tooth signal of 6.4 volts amplitude and a nominal fre-
quency of 8 cps. The output was a square wave with a nominal frequency
of 4 cps. and nominal amplitude of 5.5 volts The meanoutput amplitude
of the fifty-five was 5.481 volts (.35% less than the 5.5 volts nominal);
the maximumdeviation _rommeanwas .181 volts (3.3% of mean); and the spread
was .3 volts (5.5% of mean). In the one defective unit, there was no square
wave output. This unit was used for destructive bio-assay tests.
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B. TASK2. TESTPROGRAMANDDEMONSTRATION
i) INTEGRATEDTESTPLAN
a) Backsround and History
The test plan for the Test program and demonstration was issued in prelim-
inary form as GE document number 65SD981 on November 5, 1965, and reissued
on 20 January 1966 as revisi_l A. The revised test plan, in its entirety,
is included in this report as Appendix B.
The preliminary issue of the test plan was found generally acceptable to
NASA/LRC with the exception of the bio-assay procedures. Since preparation
of the test plan, NASA/LRC had received draft copies of Appendices B and
C to the NASA "Sterilization Handbook" on air and fall-out sampling of
clean rooms. These documents were reviewed by G.E. at LRC because they
were not yet available to Industry. G.E. altered the test plan in accordance
with the requested changes and issued it as revision A which was approved
by NASA/LRC.
Two further alterations of the program were made: the ethylene oxide
treatment in the Analog main chamber was deleted, and the bio-assay procedure
was modified. Deletion of the ETO treatment from the planned operation
provides a better simulation of the full scale operation as envisioned.
The full scale main chamber volume is so large that the use of the ETO gas
mix in this chamber is subject to considerable question for economical
operation. The change in the bio-assay procedure was made to increase the
sensitivity and accuracy of the sterility control specimen assays by using
5 ml aliquots of the sampling diluent instead of plating out the entire
50 ml suspension. By counting ten plates instead of only one large plate,
it was possible to obtain a more accurate estimate of the population.
The details of these changes are described in Appendix C hereto.
b> Plan Summar_
The test plan describes a program to provide the initial demonstration of
the technical feasibility of a facility which permits the decontamination
and sterilization of spacecraft with capability for subsequent checkout,
adjustment, repair, and encapsulation in a biological barrier under sterile
conditions. This is demonstrated using a reduced scale analogue of the
Assembly/Sterilizer Facility. The test program is composed of three major
types of tests:
Sterilization Verification
Manipulation Tests
Feasibility Demonstration
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A tabulation of the times involved in performing tasks under the various
conditions is shown as a series of ratios in Table D-IIof Appendix D. A
brief comparison of these ratios leads to the following preliminary conclu-
sions concerning the humanfactors portion of the test program:
A wide variety of commonassembly tasks can be accomplished in a
system with the configuration of the analog. It takes over twice as
long, on the average, to perform work in such a system wearing gloves
as it does working with bare hands on an open bench.
Working in a glove box offers few problems that are not present when
wearing gloves on an open bench. Themajor problem is a reduction of
visibility when performing sometasks. If the operator is able to
manipulate his work so that he can see what he is doing, it takes about
the sameamount of time to perform equivalent tasks, wearing gloves,
whether in or out of the glove box.
The time to perform a task in the analog is consistently longer than
unencumberedon an open bench.
The percentage increase in the time required to perform a task is,
roughly, an increasing function of the complexity of the task.
Similarly, four brief conclusions regarding tool selection and use are
included below. The conclusions were based on general observations and
tasks which are included with the HumanFactor portion of the test program.
The configuration of commonassembly tools is such that no major
redesign of shapes is required for their use by a gloved operator.
Most tools are madeof materials that are significantly degraded by
exposure to one or more of the three possible treatments; sterilization
by steam autoclaving, dry heat sterilization, or Ethylene Oxide/Freon
decontamination.
Several manufacturers offer lines of tools that are, generally, compat-
ible with the sterilization treatments.
Gripping tools are necessary to compensatefor the loss of dexterity
caused by wearing gloves. Satisfactory gripping tools are available
in standard designs; however, their materials maynot be acceptable.
A complete, detailed analysis of the tests which were conducted, the results
of the tests, and the conclusions derived therefrom, appear herein in Appen-
dix D.
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These tests may be summarizedas follows:
The sterilization verification tests assure that the A/S Analog chambers
are achieving the required decontamination and sterilization using the pre-
scribed treatments. These tests consist of three complete cycles of
operation of the A/S Analog subjecting a total of 150 specially prepared
specimens to the treatments of ETO/Freondecontamination, dry heat sterili-
zation. The specimenswere stainless steel strips with known, high resident
populations of viable micro-organisms.
The manipulation tests consisted of a limited humanfactor test to determine
the limitations imposed on a worker performing assigned tasks in the A/S
Analog, and problems resulting from this work environment. In addition,
tools suitable for sterile assembly and sterilization facility procedures
were investigated.
The feasibility demonstration consisted of the performance of five cycles
of A/S Analog operation including decontamination, sterilization and
sterile checkout, repair, assembly, packaging and recycle repair of a special
componentsimulating typical spacecraft hardware. A total of 50 of these
componentswere available for this program. However, 5 were shipped to
NASALangley for independent testing. In addition, 172 biologically seeded
stainless steel strips were processed during these cycles to broaden the
biological base of the demonstration.
2) MANIPULATIONTESTS
The Manipulation tests were primarily a humanfactors study to investigate
the limitations imposed on an operator by the gloves, the pressure environ-
ment, and his hand and arm movementswithin the A/S Analog. A second
objective of the tests was to makea preliminary investigation into tools
suitable for sterile assembly procedures.
In order to carry out the Manipulation Tests efficiently, the tests were
split into three phases. The purpose of the phases was to allow a wider
range of work tasks to be studied than could be accomplished by working only
on the test sample and to permit a majority of the test tasks to be performed
outside the A/S Analog. Testing outside the Analog was necessary because
time available for Manipulation Testing within the Analog was limited by
other tests being run as part of the A/S Test Program. To facilitate testing
outside of the Analog, the General Electric Companyconstructed an Assembly/
Sterilizer Analog panel simulator (mock-up) using equivalent gloves and
the samegeometry as the Analog front panel. The mock-up is illustrated
in Figure II-ii. The Analog is illustrated in Figures 11-12 through 11-15.
Phase I consisted of assembly of typical flight hardware under unconstrained
open-bench conditions (Condition A); while wearing gloves at an open bench
(Condition B); and while working through a simulated glove box panel front
(Condition C). Phase 2 was conducted under the sameconditions but using
the test sample as a test piece. Phase 3 involved assembly of both flight
hardware and test samples within the Assembly/Sterilizer Analog (Condition D).
18
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FIGURE 11-12 
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FIGURE 11-13 
REAR VIEW 
FIGURE 11-14 FIGURE 11-15 
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3) STERILITYVERIFICATIONTESTS
Sterility verification testing was included in the test plan to verify that
the Assembly/Sterilizer Analog could satisfactorily perform prescribed decon-
tamination and sterilization treatments. The test consisted of three perfor-
mancesofasterilization verification cycle. Stainless steel strips, measuring
I" x 2" x 0.06", and incubated with populations of knownviable organisms,
were subjected to ETO/FREON12 decontamination, dry heat sterilization, wet
heat sterilization, and various combinations of all three. The test results
provided a base line condition for assessment of the collected data from the
subsequent feasibility demonstration out tests.
After each sterilization or decontamination step, sample sterility control
specimenswere placed in sterile media, and incubated according tothe
biological procedure outlined in Appendix B. Following incubation, counts were
made, the results of which appear in section B of Task 3 herein.
A step by step breakdownof the verification cycle and the revised material
flow chart appear in Appendix C.
Figure II-16 is a time vs. temperature chart of the sterility verification
cycle.
4) DEMONSTRATIONTESTS
The objective of the demonstration tests was to provide laboratory verification
of the feasibility of the Assembly/Sterilizer concept for a system used to
support an interplanteary spacecraft sterilization program. The tests consisted
of performing t_pical sterilization, assembly, checkout, and packaging tasks
on test samples. A prime requirement was to perform only those operations in
the Assembly/Sterilizer which would be representative of those performed in
a full scale facility.
Five demonstration cycles were performed, two of which were designed to
demonstrate the feasibility of substituting repair parts on a previously
sterilized assembly. The remaining three cycles were considered "normal" in
that no malfunction of processed equipment was assumed. The number of test
samples used for each cycle varied between eight and fourteen, and permitted
the destruction bio-assay of eight test samples after each cycle. The tempera-
tures of all the test samples were monitored during testing.
The test samples were subjected to performance tests before processing in
the demonstration cycles. These tests were repeated prior to sterilization,
after sterilization, and at the end of a twenty hour life test. No
significant changes in pulse shapes, signal levels, or frequency rates
of the test samples resulted from ETOdecontamination, dry heat steriliz-
ation, or the life test. This was the expected result based on the experience
from the qualification testing previously performed on the test sample
breadboard.
A summaryof the distinguishing features of the five demonstration cycles
is included in Table II-II.
21
Figure II-16 Time vs. Temperature Chart 22
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In the normal cycle (Cycles I, 3 and 5) the primary objective was to serve as
a "control" so that significant changes in the operation of the equipment
could be detected.
In the repair cycle (#2), it was assumed that all of the test samples in the
main chamber had an indicated malfunction in the post sterilization checkout.
A simulated repair was effected by introducing an equal quantity of test
samples through the auxiliary chamber. The electronics from the replacement
units were substituted for the electronics on the failed units and vice versa.
The purpose of this test was to demonstrate that repairs can be made to a
sterile unit without violating sterile conditions or re-sterilizing the failed
unit.
The re-cycle repair cycle (#4) was similar to the repair cycle except that it
involved the introduction of a sterile test sample, in a container, into the
sterile main chamber thus simulating repair of an on-pad failure of a sterile
spacecraft. Because of the small physical size of the test sample and its
container with the consequent thermal lag, the autoclave was used to pass
the sterile test samples into the main chamber. This permitted rapid surface
sterilization of the test sample container and greatly reduced the probability
of killing any viable organisms which might be on the test sample itself.
This concept was verified by the simulatneous processing of S/C specimens in
the same manner. After the recycled test samples were introduced to the
main chamber, a repair was _imulated as in Cycle No. 2 The results obtained
by performing bio-assays on the sterility control specimens were satisfactory.
A complete, detailed analysis of the test results appears herein in Task 3.
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C. TASK3. BIO-ASSAY
The objectives of the bio-assay portion of the Assembly/Sterilizer program
were met satisfactorily. The data showedthat ethylene oxide decontamina-
tion reduced the microbial populations by at least three and as muchas
eight decades, sterilization was effected by the dry heat and steam c_cles
uniformly throughout the chambers, and there was no incidence of recontam-
ination of either the assembled Test Samplesor the Sterility Control
Specimensduring any of the cycles.
I) BIO-ASSAYPLANNING
a) Experimental Rationale
The bio-assay test plan was devised to monitor the microbiological functions
of the Assembly/Sterilizer analog, its efficacy in decontaminating, steri-
lizing, and maintaining sterility of spacetype hardware through assembly
and testing. The specific objectives of the bio-assay tasks performed were
to demonstrate the effectiveness of the ethylene oxide decontamination cycle
in reducing microbial populations, to confirm temperature measurements
indicating lethality of dry heat sterilizing cycles, and to detect microbial
contamination if introduced to the test samples or sterility control speci-
mem_subsequent to sterilization.
Because it is anticipated that major systems of spacecraft processed according
to the Assembly/Sterilizer concept would be assembled in bio-clean facilities
prior to decontamination and sterilization in the partially assembled state,
the test samples were put through a similar process. Structural parts were
assembled under normal manufacturing conditions and decontaminated by
heating. Electronic piece parts were cleaned and bagged prior to assembly
on a clean bench, and all parts were bagged for storage until they were
used in the analog. This entire process was monitored according to procedures
employed throughout NASA*to enable comparison of the results obtained
with those of other investigators.
Because the magnitude of the population anticipated on the assemblies and
piece parts was small, it was decided to supplement the resident populations
with large numbers of dry-heat resistant bacterial spores.
The relatively small numbers of samples would have limited the obtainable
data; therefore, additional spore preparations were employed in large numbers,
enabling more complete distribution throughout the analog and increasing
the confidence in the data obtained. In addition to temperature, the
resistance of spores is a function of the atmospheric composition, parti-
cularly oxygen and water vapor concentrations. In a system as geometrically
complex as the analog, it was necessary to demonstrate that the local
environments within the chamberswere sufficiently uniform to achieve
sterilization reliably. This is effectively and conveniently demonstrated
with microbiological controls.
*Paragraph C, "Method of Sampling Fallout Contamination Onto Surfaces" -
Interim Requirements for Bio-Clean Facilities, Appendix B, Hq, National
Aeronautics and Space Administration. 25
b) Procedure Selection
(i) Test SampleBio-assay
(a) Bio-assay of Fabrication Facilities
Standard NASA*procedures were chosen for bio-assy of the clean bench
and the clean roomhousing the analog. Reynier samples and fallout strips
were employed as described in Appendix B.
(b) Bio-assy of Test SampleHardware
Piece parts and sub-assemblies were bio-assayed for surface microbial
population only consistent with the intent of the program to demonstrate
asceptic assembly and testing. The assays were performed in accordance
with standard NASA*procedures as described in Appendix B.
(2) Preparations for Sterility Verification and Demonstration Cycles
(a) Preparation of Sterility Control Specimens
Spores of Bacillus subtilis var. niger were chosen for evaluation of the
ethylene oxide decontamination and dry heat cycles because they exhibit
relatively high resistance to these agents, produce colonies of characteristic
morphology, and have been employed widely as sterilization indicators.
Spores of Bacillus stearothermophilus were chosen for application in steam
sterilization as they are standards in the industry and possess exceptionally
high moist heat resistance. Both organisms were employed on stainless steel
strips in populations of approximately 106 , 108 , and 109 per strip as
described in Appendix B.
(b) Inoculation of the Test Samples
8
Test samples were inoculated with i0 spores of B. subtilis var.
to supplement the resident microbial population.
(3) Sterilization Verification Cycles
The principal purpose of the Sterilization Verification Cycles was to
demonstrate the readiness of the various chambers of the analog to perform
the decontamination and sterilization tasks before proceeding with the
demonstration cycles. A second objective was to check out the bio-assay
procedures that would be employed in the demonstration cycles.
The normal cycle of ethylene oxide decontamination, sterilization, mani-
pulation and assay was employed. In evaluating decontamination, samples
were removed in sterile containers and bio-assayed by normal viable counting
procedures to determine the reduction in population attributable
Paragraph C, "Method of Sampling Fallout Contamination Onto Surfaces" -
Interim Requirements for Bio-Clean Facilities, Appendix B, Hq, National
Aeronautics and Space Administration.
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to the ethylene oxide environment. The specimens to be subjected to
dry heat were sealed in jars during the decontamination cycle to protect
them from the ethylene oxide environment. Sufficient specimens were
included that five from each group of sealed specimens were removed for
assay before the heat cycles to verify the viable population, demonstrating
the integrity of the seal. The remainder were deployed throughout the
chambers for dry heat sterilization, and finally assayed for sterility in
aerobic broth medium. The details of the cycles can be found in Appen-
dices B and C.
(4) Demonstration Cycles
The principal purpose of the demonstration cycles was to demonstrate the
capability of the various chambersof the analog to perform the decontam-
ination and sterilization, These were, to decontaminate and sterilize
electronic piece parts and structural sub assemblies, to demonstrate the
effectiveness of each cycle, and to show they could be built, tested,
repaired and maintained asceptically for prolonged periods of time. This
was accomplished through the use of a multitude of control specimens as
noted in the test plans in Appendices B and C.
Control specimens consisting of previously inoculated stainless steel
strips were utilized to demonstrate the effect of each cycle with all
bio-assaying accomplished in the analog to eliminate the possibility of
contamination due to handling.
As an additional control, the electronic piece parts and portions of
materials of the structural sub assemblies were individually seeded to
exhibit growth. This demonstrated that the pieces in themselves were
neither bacteriostatic nor bacteriocidal by nature of their chemical
composition.
c) Evaluation of Results
Performance of the Sterilization Verification Cycles and the Demonstra-
tion Cycles without a single instance of failure in sterilization or
detected breach of sterility is essential to the acceptance of the
Assembly/Sterilizer as a valid concept. The degree of assurance required
by the Planetary Quarantine requirements for interplanetary exploration
that sterility is not violated cannot practically be developed solely by
experimentation because of the numberof experiments required. Such
assurance will have to be gained analytically. Consequently, results
indicating no violation of sterility cannot of themselves confirm the
feasibility of the concept, but a single violation of sterility is an
unequivocal indicator of a flaw in the system.
Caution must be exercised in applying the effectiveness of ethylene oxide
decontamination experienced in the analog system to other ethylene oxide
systems. The conditions attained in the decontamination modeof operation
were not optimal for ethylene oxide decontamination as unexplained varia-
tions in ethylene oxide, freon and air concentration occurred throughout
the program.
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The microbial population associated with the clean room in which the
Assembly/Sterilizer is located was examined in an attempt to establish
any specific trends for an analysis. The fallout samples present
data which is so widely spread that no pattern is evident. Larger sample
quantities at more frequent intervals would have to be taken to develop
a pattern of accumulation and die off.
3The airborne population density average was .21/ft with an average
upstream population of .18/ft 3 and downstreamp6pulation of .24/ft 3.
The laminar flow clean bench exhibited an airborne population of 1.3 x 10-2
counts/ft 3 and a fallout population ranging from 0/ft _ to 720/ft 2 over
a two week period. With an average of:
75 Aerobic non heat shocked / FT 2
30 Aerobic heat shocked / "
0 Anaerobic heat shocked / "
0 Anearobic non heat shocked / "
/ 2 Weeks
11 I!
11 II
_ IW
The microbial population on the test samples was found to be very low as
anticipated. The average count for the components and piece parts of an
assembly was 10.2 - aerobic nonsporeformers; II.0 - aerobic sporeformers;
4 - anaerobic nonsporeformers and 0 - anaerobic sporeformers.
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2) BIO-ASSAYPERFORMANCEANDRESULTS
a) Test SampleBio-assay
(i) Air SampleBio-assay of the test sample fabrication facility environ-
ment in and about the class i00 laminar flow bench.
Thirty-six hours of air sampling were performed: 4 hours of room environment
sampling and 32 hours of clean bench sampling. The petri dishes from the
Reynier samplers were prepared and incubated in accordance with the test
plan of Appendix B. A total of 25 colonies resulted from the incubation of
the bench air samples. Since the rate of sampling is one cfm, this gives an
average colony population in the bench air of 25/(32 x 60) = 1.3 x 10-2 colonies
per cubic feet. The data from which this average was derived are presented
in Table II-III.
_enty-four fallout strips were also placed in the laminar flow bench, and
removed for bio-assay at periodic intervals (4, 6, 12, & 17 days). The
bio-assay of these strips gave computedaverage fallout accumulations of
one hundred colonies per square foot for aerobic, non-heat shocked, sixty
colonies per square foot for aerobic heat shocked, and zero colonies per
square foot for anaerobic heat shocked and non-heat shocked. These averages
are derived by weighting the data of table If-IV by the numberof strips for
each sample. It should be noted that the data in the tables represents a
total of only seven colonies which resulted from the assay of the twenty-four
strips. This very low count is due to the fact that the environment sampled
is a bio-clean bench in a quasi-clean room. The resultant count is too low
to try to draw statistically significant conclusions from the data.
Figure If-17 shows the placement of the Reynier samplers and fallout strip
trays on the bench during normal working conditions and during air sampling.
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TABLE II- IV
BIO-ASSAY RESULTS OF FALLOUT SAMPLES ON CLEAN BENCH
Date (Note i)
1/25/66
(Note 2)
1/27/66
(,Note 3),,
2/3/66
(Note 3.)
2/7/66
COLONIES PER SQUARE FOOT (Notes 4,51&6 )
AEROBIC ANAEROBIC
Non-heat
Shocked
Heat-
Shocked
120
Non-Heat
Shocked
0
"--- 0
0 --- 0
6O 0 0
240
0'
Heat-
Shocked
0
0
NOTES:
(I) Strips set out on 1/21/66
(2) Average of colonies from 6 fallout strips - rinse method
(3) Average of colonies from 3 fallout strips per incubation condition -
agar immersion method
(4) All controls negative
(5) Sample computation for 1/25/66 aerobic non-heat shocked
Strip size - i" x 2" = 2 in. 2
Number of strips = 6
Total strip area = 6 x 2 in. 2 = 1/12 ft. 2
Aliquot fraction = 1/5
Number of colonies = 4
Colonies/ft.2 = Number of colonies = 4
Aliquot fraction x Total strip area
240 colonles/ft. 2
(6) Sample computation for aerobic non-heat shocked average colonies per
square foot:
Colonies/ft. 2 =X(colonies/ft. 2 for each sample) x (numbers of strips)
Total number of strips
2
= 240 x 6 + 0 x 3 + 0 x 3 + 60 x 6 = 1800 = i00 colonles/ft.
18 18
(I/5)x(I/12)
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(2) Bio-Assay of Test Sample Hardware
Bio-assay of the test sample consisted of assaying electronic piece
parts, wired and unwired printed circuit boards, and base assemblies in
accordance with the test plan (except as noted below). Ninety-five piece
parts, representing sets of parts for five test samples were assayed. There
were a total of 18 colonies observed giving an overall average of 0.19
colonies per part. The data from this assay are presented in Table II-V.
TABLE II-V
Part
Type
BIO-ASSAY RESULTS ON ELECTRONIC PIECE PARTS
Colonies/Sample (Note i)
Sample Parts/ Non-Heat Shocked Heat Shocked
No. Sample Aerobic Anaerobic Aerobic Anaerebi_
(Note 2) (Note 2_
Resistor i 8 0 0 0 0
2 8 0 0 0 0
3 8 0 0 1 0
4 8 0 0 2 0
5 8 0 0 0 0
Terminal I 5 0 0 0 0
2 5 0 0 0 1
3 5 0 0 0 0
4 5 0 0 0 0
5 5 5 0 2 0
Transistor i 2 0 0 0 _
2 2 0 0 0 0
3 2 I 0 0 o
4 2 i 0 0 0
5 2 I 0 0 0
Diode 1 2 0 0 0 0
2 2 0 0 0 0
3 2 0 0 0 0
4 2 0 0 I 0
5 2 0 0 0 0
Capacitor i 2 i i 0 0
2 2 0 0 0 0
3 2 0 0 0 0
4 2 0 0 0 0
5 2 i 0 0 0
Sterility
Control
(Stainles_ Steel
Strip)
I 0 0 0 0
i 0 0 0 t,
i 0 0 0
*NOTES ON NEXT PAGE
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NOTES : 
(1) For each part type: Colonies/part (average) = Colonies/Sample ~~ 
Parts/Sample 
(2) Culture Controls on Anaerobic Incubation 
C. sporogenes - all positive 
A. faecalis - all negative 
During the seventy two hours of incubation for the piece parts, 
corrosion occurred on some of the part types. It appeared on 
the zinc plated copper leads of the resistors and on the under- 
side of the transistor bodies. Figures 11-18, 19, and 20 show this 
corrosion. It was verified that this was corrosion, and not 
microbial growth, by transferring samples of the corrosive products 
to fresh media and then incubating. The results were negative. 
It was further confirmed that this growth was not inhibitory to 
microbial growth by streaking the face of representative plates 
with A. faecalis and then incubating the plates. The corrosive 
products were observed to cause no detectable zone of inhibition. 
The results from this latter test are shown in Figure 11-20 
FIGURE 11-18 
TYPICAL TRANSISTOR ASSAY PLATE 
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.FIGURE II9.19 
TYPICAL RESISTOR ASSAY PLATE 
FIGURE 11-20 
TYPICAL RESISTOR ASSAY PLATE 
WITH INHIBITION TEST STREAKS 
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Fiv_ _nwired printed circuit boards were assayed. Each board was
broken into three pieces so that they could be placed in tubes for
washing in sterile 1%peptone water. The data from the assay is
presented in Table II-VI, The overall averages of colonies per
board are non-heat shocked aerobic 6 per board, and anaerobic 2 per
board, and heat shocked aerobic 48.5 per board and anaerobic one
per board. (Each board has a free surface area of about 14 square
inches).
TABLEII-VI
BIO-ASSAY RESULTS OF CIRCUIT BOARDS (Note 2)
Circuit
Board #
3
4
5
Sterility
Control
Non-Heat Shocked
Rinse Aliquot
Aerobic I Anaerobic(Note i)
i
3
4
Heat Shocked
Rinse Aliquot
Aerobic I Anaerobic(Note i)
0
I
0
0
0
i
I
0
0
0
3
17
30
0
0
0
Plated Pieces
Aerobic
2
0
NOTES:
(I) Culture controls on anaerobic incubation
C. sporogenes - all positive
A. faecalis - all negative
(2) Each of the numbers for aliquots represents a i/i0 aliquot.
Thus a sample calculation for the average colonies per board for
Aerobic heat shocked is:
Number of boards - 5
Total count from rinse aliquots - 67
Aliquot fraction - 3/10
Total count from plated parts - 19
Colonies/board = Total count from aliquots
Number of boards x Aliquot fraction
+ Total count from
plated parts
Number of boards
= 67 +
5 X 3/10
9 ._
-- = 48.5 colonies/board
5
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Five wired test sample printed circuit boards (SN 8, 19, 38, 51 and 56)
were bio-assayed to define the pre-test condition for the test cycles of
Task 2. With the exeeptlem of SN56, the total reduced count was II aerobic
non-heat-shocked organisms on four samples with a total surface area of ahout
80 square inches. This gives an average surface count of 20 organisms per
square foot. Culturing of the aliquots from SN 56 resulted in populations
too numerous to count* The data from the assay are contained in Table II-VII.
TABLEII- VII ASSEMBLEDPRINTEDCIRCUITBOARD
MICROBIOLOGICALSSAYS
(Notes i & 2)
Sample
Serial No.
8
19
38
51
56
CONTROL
Non-Heat Shocked
Aerobic Anerobic
i (5) 0
1 (5) 0
0 0
0 0
TNTC 0
0 0
Heat Shocked
Aerobic Anaerobic
0 0
0 0
0 0
0 0
TNTC 0
0 0
Plated Parts
Aerobic Non-
Heat Shocked
0
0
0
1
TNTC
0
NOTES:l.Control Samples on Anaerobic incubation
sporogenes Pos.
A faecalis Neg.
2.The numbers I (5) represent a count of one in a 20% aliquot
giving a reduced count of 5.
J. Analysis of the growth from the assay of sample SN 56 has shown it to
be morphologically identical with B. subtillis var. nii_ which, during
the period of these assays, was being used in massive quantities in the
biological laboratory. Thus, this growth is attributed to laboratory
contamination of the specimen.
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Five test sample base assemblies were bio-assayed. To handle, cut, and pull
apart the assemblies, sterile pliers, forceps, and shears were used. Com-
ponent #SN-45was cut randomly into pieces small enough to fit into peptone
water bottles, and attempts were madeto flatten out the carious pieces so
as to fit properly in the culture plates. This procedure, however_was
found to be too awkward, and the following step-by-step plan was therefore
developed for all subsequent components.
After each componenthad been asceptically removed from its container and
placed ,,n a sterile tray, sterile shears were used to cut the thermocouple
wire at its junction with the heat shield material, and the wire was placed
in a peptone water bottle. Using two pairs of sterile pliers (one to hold
the skin and its adherent heat shield material) the four brackets
were pulled from the skin and all four were placed in a single peptone water
bottle. Finally, the skin and its adherent heat shield material were sheared
lengthwise into approximately equal parts. With component#SN-36each of
the two halves was immediately placed in its individual peptone water bottle,
but to insure proper immersion in the peptone water subsequent component
half sections were cut into quarters and the two quarter sections placed in
a single bottle. As a control for each component, a sterile stainless steel
strip was also placed in a peptone bottle. The componentparts and the
sterile stainless steel control strips were then bio-assayed according to the
test plan. The assay results are presented in Tables II-V%II A through
II-VII_E. The overall averages of colonies per base assembly are: non-heat
shocked aerobic, 7.4 per assembly, anaerobic, ii per assembly; and heat
shoked aerobic, 4 per assembly; and anaerobic, zero. Each base assembly Nas
a total surface area of approximately 35 square inches.
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TABLEII- VIII A
BIO-ASSAY RESULTS ON BASE ASSEMBLIES
Base Assembly SN_#45
Parts: Tube #i - bracket and skin and heat shield material
Tube #2 - bracket and skin and heat shield material
Tube #3 - bracket and skin and heat shield material
Tube #4 - thermocouple wire
Tube #5 - control plate
Anaerobic Culture Controls
A. faecalis - all negative
_. sporo_enes - all positive
Tube #
4
Note I
Total counts
per component
(non-heat shock.
ed aerobic in-
cludes plated
parts)
Non-Heat Shocked
Rinse Aliquot
Aerobic I Anaerobic
Plated Parts
Aerobic
0
0
Heat Shocked
Rinse Aliquot
Aerobic i Anaerobic
1 0
0 0
0 0
0 0
0 0
2 0
I 0
0 0
0 0
0 0
23 0
0
0 0
0 .0
i 0
0 0
i 0
0 0
0 0
0 0
0
0
i0
0
0
0
NOTE I: Calculation of total counts:
Aliquot fraction per tube = 1/5
Total count = E culture count
Aliquot fraction
For aerobic non-heat shocked, the culture count from the plated parts is
added to the summation to give the total count.
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TABLEll-Vlll B
BIO-ASSAY RESULTS ON BASE ASSEMBLIES
Base Assembly SN_#36
Parts: Tube #i - brackets (4)
Tube #2 = skin & heat shield (One 1/2 section)
Tube #3 - skin & heat shield (One 1/2 section)
Tube #4 - thermocouple wire
Tube #5 = control plate
Anaerobic Culture Controls
A. faecalis - all negative
_. sporosenes - all positive
Tube #
Note i
Total counts
per component
(non-heat shock
ed aerobic in-
cludes plated
parts)
Non-Heat Shocked
Rinse Aliquot
Aerobic
0
0
0
0
0
0
0
0
0
0
0
I Anaerobic
0
3
0
0
0
0
0
0
15
Plated Parts
Aerobic Aerobic
Heat Shocked
Rinse Aliquot
Anaerobic
0
0
0
0
0
0
0
NOTE i: Same as Note i on Table II-5A
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TABLEII -VIII C
BIO-ASSAY RESULTS ON BASE ASSEMBLIES
Base Assembly SN_#42
Parts: Tube #I - brackets (4)
Tube #2 - skin & heat shield (Two 1/4 sections)
Tube #3 - skin & heat shield (Two 1/4 sections)
Tube #4 - thermocouple wire
Tube #5 - stainless steel control strip
Anaerobic Culture Controls
_. faecalis - all negative
_. sporogenes - all positive
NOTE: Peptone volume was I00 cc for this component.
Tube #
4
Note 1
Total counts
per component
(non-heat shock
ed aerobic in-
cludes plated
parts)
NOTE I:
Non-Heat Shocked
Rinse Aliquot
Aerobic _ Anaerobic
0 4
0 0
Plated Parts
Aerobic
Invalid - Sample dropped
0
0
0
0
0
0
0
0
40
0
4
0
Heat Shocked
Rinse Aliquot
Aerobic
0
0
Anaerobic
0
0
0
0
0
0
0
Same as Note I on Table II-5A except aliquot fraction per tube is I/I0.
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TABLEll-Vl!l D
BIO-ASSAY RESULTS ON BASE ASSEMBLIES
Base Assembly SN_#21
Parts: Tube #I - brackets (4)
Tube #2 - skin and heat shield (Two 1/4 sections)
Tube #3 - skin and heat shield (Two 1/4 sections)
Tube #4 - thermocouple wire
Tube #5 - stainless steel control strip
Anaerobic Culture Controls
A. faecalis - all negative
_. sporosenes - all positive
Tube #
2
4
Note I
Total counts/
components
(non-heat shock-
ed aerobic in-
cludes plated
parts)
I Non-Heat Shocked
Rinse Aliquot
Aerobic Anaerobic
0 0
0 0
0 0
0 0
0 0
2 0
0 0
0 0
0 0
0 0
i0 0
Plated Parts
Aerobic
Heat Shocked
Rinse Aliquot
Aerobic z Anaerobic
0
0
0
I
0
0
0
0
0
0
0
0
0
0
NOTE I: Same as Note 1 on Table II-5A.
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TABLEII-VTII E
BIO-ASSAY RESULTS ON BASE ASSEMBLIES
Base Assembly SN_#44
Parts: Tube #i - brackets (4)
Tube #2 - skin and heat shield (two 1/4 sections)
Tube #3 - skin and heat shield (two 1/4 sections)
Tube #4 - thermocouple wire
Tube #5 - stainless steel control strip
Anaerobic Culture Controls
A. faecalis - all negative
_. sporo_enes - all positive
Tube #
4
Note i
Total count/
component (non-
heat shocked
aerobic in=
cludes plated
parts)
Non=Heat Shocked
Rinse Aliquot
Aerobic Anaerobic
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Plated Parts
Aerobic Aerobic
0
0
0
0
0
Heat Shocked
Rinse Aliquot
Anaerobic
0
0
0
0
NOTE i: Same as Note 1 on Table II-5A
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b) SpecimenPreparation for the Verification and Demonstration Cycles
(I) Preparation of fall-out strips for the bio-clean room in which the
Assembly/Sterilizer Analog was installed.
Three hundred (300) stainless steel strips were prepared and cleaned
as outlined below. (See Appendix B)
a)
b)
c)
d)
e)
f)
Wipe both sides with acetone
Wash with Haemo-Sol in hot water
Rinse three times with hot distilled water
Rinse with isopropanol
Rinse with ethyl ether
Dry
Just prior to use the strips were placed on stainless steel trays, in groups
wrapped in aluminum foil, and sterilized.
(2) Preparation of Sterility Control Test Specimens
Five hundred seventy (570) stainless steel strips were prepared, cleared,
and sterilized as above. Following sterilization, theu were inoculated
with test organisms as indicated in the test plan (See Appendix B).
Table II- IX identifies the organisms, and includes the calculated nominal
populations, quantity of specimens prepared and counted, and the counted
mean populations and standard deviations. Counting was done on a sampling
basis only, as the bio-assay of the count on a specimen removes the popu-
lation. Bio-assays were performed as outlined in the test plan (Appendix B).
A modification to the Test Plan was incorporated (See Appendix C) to include
the use of ultrason_s to aid in the removal of spores from the sterility
control strips. The spores could not be completely removed from the strips
by immersing in peptone]tween diluent and shaking on a reciprocating shaker.
All spores were completely removed after 5 minutes exposure to ultrasonics.
The maximum viable population o_ B. stearothermophilus which has been demon-
strably achieved is 4 x 108 . The spore suspension w_s prepared and h_rvested
according to the test plan. When sporulation was microscopically 90 percent
complete, direct counts on the number of spores was determined with _ Petroff
Hauser counting chamber. The results indicated a spore count of 5.5 x i0 II
However, when a viable count was made a concentration of 4.6 x 108 viable
spores was found. This appears to be the highest concentration of spores
which it is practical to prepare on a test specimen of this type, based on
viable count. Fifty stainless steel strips were prepared using the spore
counts obtained in the Petroff Hauser chamber. The inoculum was 2.75 x i09,
spores per strip. Four of these strips were bio-assayed with the results
shown in group6 of Table II-IX.
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TABLEII-IX SUMMARYOFTESTSPECIMENSPREPARED
Group Test Calculated
Organism Nominal No. of Specimens
Specimen
Population Innoculated Counted
1 B. Subtilis 106 I00 I0
var. ni e$_e_
IA B. subtilis 106 50 --
var. niger
2 B. subtilis 108 i00 I0
varY-niger
2A B. Subtilis 108 40 --
var. niger
2B B. Subtilis 108 30 --
var.
Counted Mean Populations snd
Standard Deviations
Non heat
Heat Shocked shocked
Mean: 1.2x105
Std. Dev. 0.28x
105
Mean: 5.1xlO 7
Std. Dev. 1.5x
107
3 B. Subtilis 109 i00 i0 Mean: 1.8x109
var. niger Std. Dev. 0.3x
1.0 9
4 B. Stearo- 106 50 i0 Mean: 2.4xi05
thermophilus Std. Dev. 0.39x
105
5 B. Stearo 108 50 I0 Mean: 1.Ixi08
thermophilus Std. Dev. 0.22x
108
Mean: 1.2xi05
Std. Dev: 0.28
xl05
6 B. Stearo 109 50 4 Mean: l.ixlO 6
thermophilus Std. Dev. 0.41x
106
Mean: 6.0xl07
Std. Dev. 0.96
xl07
Mean: 2.1xi09
Std. Dev. 0.35
xl09
Mean: 5.0x105
Std. Dev. 1.0
xl05
Mean: 2.4xi08
xl08
Mean: 2.75xI_
Std. Dev. 0.87
xlO 6
The above table includes the additional sterility control specimens which were
prepared due to two prematurely terminated verification cycles. Also included
are the 40 specimens in the iron-constantan thermocouples _tt_ched. (Group 2A)
The highest calculated population of B. subtilus var niger spores that would
consistently adhere to the sterility control specimens without excessive loss
due to flaking off was approximately 2.5xi09. The test plan (Appendix B)
specified a nominal population of I0 I0. The sterilization treatments pre-
scribed by NASA Headquarters are predicated on a total lander population of
108 . Thus, in every cycle, test specimens were used which bad significantly
greater populations than the populations on which the sterility treatments
used in the program was based.
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Part of the problem of higher assay counts may be due to the characteristic
difficulty in heat activating spores of B. stearothermophilus. The counts
obtained do not necessarily represent the true number of viable spores present,
but represent only the number which were susceptible to the initial heat acti-
vation. This characteristic of the spores may be expected to vary from culture
to culture, as those factors which control dormancy of B. stearothermophiilus
spores are not understood.
(3) Inoculation of One-half of the Structural Subassemblies to be used
in the Demonstration Cycles.
Twenty-two (22) structural subassemblies were inoculated with nominal popu-
lations of 108 spores of B. subtilis var. _ige____r.Inoculations were made
on the aluminum skin near the point where the thermocouple lead-in wire
was attached. No in situ counts were made, as bio-assays of these samples
would have necessitated destruction of the subassemblies.
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c) Test Results
(i) Verification Cycles
After installation and preliminary testing of the Assembly/Sterilizer
Analog was completed, Verification Cycle #I was initiated.
(a) Verification Cycle #I
Fifty sterility control test specimenswere processed in the facility
as indicated in Verification Cycle #i in Appendix B. The test specimens
were in four groups, (A, B, C, & D) each of which contained specimens
with nominal populations of 106, I0_. and 109 organisms. The utilization
of these specimens is described in Table II-X.
TABLEII-X
Group Quantity
A I0
B 5
I0
C 5
i0
D i0
UTILIZATION OF STERILITY CONTROL SPECIMENS
Processing
ETO decontaminate specimens in auxiliary chamber
*ETO decontaminate container in auxiliary chamber
*ETO decontaminate container in auxiliary chamber
and sterilize specimens in main chamber
*ETO decontaminate container in auxiliary chamber
*ETO decontaminate container in auxiliary chamber
and sterilize specimens in auxiliary chamber
Sterilize specimens in autoclave
Group A, B, & C specimens seeded with B. subtillis var. niger;
Group D specimens seeded with _. stearothermophilus
*Specimens introduced into chamber in cans to verify that ETO/freon
decontamination has little effect on populations unless in direct
contact with them.
The fifty sterility control specimens were bio-assayed as follows:
i0 specimens (Group A) to determine the effectivity of the ETO/FREON
decontamination in the Auxiliary chamber.
5 specimens from each of two groups (B and C) to determine if any
inadvertent decontamination of these specimens occured during their
exposure, in sealed containers, to the ETO/FREON treatment in the
auxiliary chamber.
i0 specimens (Group C) to determine the efficacy of the dry heat
sterilization in the auxiliary chamber.
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I0 specimens (Group B) to determine the efficacy of the dry
heat sterilization in the main chamber.
I0 specimens (Group D) to determine the efficacy of the wet heat
sterilization in the autoclave.
Group A specimenswere arranged in the auxiliary chamberas shownin
Figure 11-21. The numbers in the blocks indicate the meminal pretreatment
populations.
FIGURE 11-21 Group A Arrangement During
ETO/FREON Treatment
Auxiliary Chamber Rear Door
._ #A-I
#A-2
#A-3
#A-5
i--_09 #A-6
_#A-7
_#A-8
_#A-9
_ I06] #A-10
The results of the Bio-Assay of Group A in Table II-XI were tabulated
according to Standard Method%American Public Health Association.
TABLE ll-Xl. GROUP A ASSAY RESULTS
Population
Specimen
A-I
A-2
A-3
A-4
A-5
A-6
A-7
A-8
A-9
A-10
Pre-Treatment
_nominal)
106
109
108
108
106
109
108
106
109
106
Post-Treatment
1.5 x 104
1.5 x 104
1.5 x 104
1.5 x 104
1.5 x 104
13
1.5 x 104
lost through breakage
0
2
See next page for notes)
5O
Note: (I)
Note: (2)
Plates were made with 1.0 ml and 0.I ml aliquots of the
50 ml suspension of peptone/tween media. The remaining
suspension including the stainless steel strips were then
plated together.
A post ETO/FREON reexamination indicated that by plating the
sterility control strip and peptone/tween suspension, colonies
were too numerous to count. Therefore, the procedures for
subsequent verification and demonstration cycles were modified
(see Appendix C), permitting the remaining suspension to be
plated in 5 ml aliquots.
Five specimens each from Group B and Group C as described in Table II-X
were bio-assayed. The results are shown in Table II-XII.
TABLE II-XII
Group
B
Bio-Assay of Group B and C Canned Specimens
Population
Specimen # Pretreatment Post Treatment
(nomina i) 4
Ii 106 6.0 x i0
12 106 3.0 x 106
13 108 1.9 x 107
14 108 1.9 x 107
15 109 7.0 x 108
16 106 1.5 x 104
17 106 1.5 x 104
18 108 1.5 x 106
19 109 1.5 x 106
20 109 1.5 × 107
The reduction of population of some of these specimens appears to have
resulted from container seal leaks; steps were taken to prevent repetition
of this problem, but subsequent data still showed some population re-
duction.
The specimens of group B exposed to the dry heat sterilization treatment
were arranged in the main chamber as shown in Figure 11-22. The assay of
these specimens (post sterilization) showed no growth in a seven day
incubation period.
51
FIGURE11-22 Group B ArrangementDuring
Dry Heat Sterilization
m
#6 #7 #8 #9 #i0
#11 #12
IT/C Strip I IT/C Strip I
#i #2 #3 #4 #5
D D D
NOTE:
FRONT OF MAIN CHAMBER
i. T/C strips had Iron Constantan thermocouples attached.
2. Numbers in blocks are nominal pre-treatment population.
The specimens of Group C exposed to the dry heat sterilization treatment
were arranged as shown in figure II-23. The assay of these specimens
(post sterilization) showed no growth in a seven day incubation period.
FIGURE II-23 Group C Arrangement During
Dry Heat Sterilization
NOTE:
Rear of Auxiliary Chamber
#18 #13
_#19 #14_
_#20 #15_
_#21 #16
_'_#22 #17_
Numbers in blocks are nominal pre-treatment population
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The specimens of group D were exposed to wet heat sterilization in the
autoclave. They were arranged as shown in Figure II-24. The assay of
the specimens (post sterilization) showed no growth in a seven day
incubation period.
FIGURE I1-24 Group D Arrangement During
Wet Heat Sterilization
Rear of Autoclave
#28 _ #23
4#29 _ 4#24
_ #30 _ 4#25
4#31 _ 4#26
['_ #32 ['10"_ #27
NOTE: The numbers in the blocks are nominal pre-treatment population
(b) Verification Cycle #2
Fifty sterility control test specimens were processed in the facility as
in Verification Cycle #i. (See Table If-X). The test specimens were in
four groups (A, B, C, & D) each of which contained specimens with nominal
populations of 106 , 108 , and 109 organisms. The group A specimens were
bio-assayed after ETO/FREON decontamination and yielded a spread of counts/
strip from 3 to 71 with a mean of 15.1. The results of the individual
mpecimens are presented in Table II-XIII.
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TABLEII-XIII
BIO-ASSAYOFGROUPA SPECIMENS
Population
Pre-Treatment
Specimen# (nominal) Post Treatment
A-I 106 17
A-2 109 4
A-3 108 3
A-4 108 16
A-5 106 6
A-6 109 8
A-7 108 7
A-8 106 6
A-9 109 13
A-10 106 71
n
See Note 2 - Table II-XI
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The GroupB and C specimens represented nominal pre-treatment populations
of 106, 108, and 109 organisms per strip. The assay of the 5 strips from
each group which had had the containers exposed to ETO/FREONbut had no
further treatment yielded a spread of 7 x 103 to i x 109 counts/specimen.
The data for the individual specimens is presented in table II-XIV.
TABLEII-XIV
Bio-Assay of GroupB and C CannedSpecimens
Group B
Population
Specimen# Pre-Treatment Post-Treatment(nominal)
4Ii 106 3.3 x i0
12 106 6.8 x 104
13 108 2.4 x 107
14 108 2.4 x 107
915 i0 1.0 x 109
Group C 16 106 1.9 x 105
17 106 7.0 x 103
18 108 8.9 x 106
19 i0 8 1.0 x 107
20 109 8.9 x 107
The remaining group B and C sterility control strips were bio-assayed
after dry heat sterilization and were found to be sterile. The thermo-
couple strips were also assayed and found to be sterile.
The group D specimens represented nominal pre-treatment populations of 106
108, and 109 organisms per specimen. All strips were assayed after steam
sterilization and found to be sterile.
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(c) Third Verification Cycle
Fifty sterility control test specimenswere processed in the facility
as indicated in Verification Cycles I and 2. The test specimenswere in
four groups (A, B, C, and D), each of which contained specimenswith
nominal populations of 106, 108, and 109 organisms.
The Group A specimenswere bio-assayed after ETO/FREONdecontamination
and yielded a spread of 6,500 to 130,000 with a meanof 26,050. The
results of the individual specimensare presented in Table II-XV.
TABLEII-XV
Results of Bio-Assay of Group A Specimens
Specimen#
A-I
A-2
Ak3
A-4
A-5
A-6
A-7
A-8
A-9
A-10
Population
Pre-Treatment
(Nominal)
106
109
108
108
106
109
108
106
109
106
Post Treatment
1.7 x 104
1.7 x 104
1.5 x 104
i. 3 x 105
1.6 x 104
I.I x 104
1.7 x 104
1.5 x 104
1.6 x 104
6.5 x 103
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The assay of the 5 strips from each of groups B and C which had had their
containers exposed to ETO/FREONbut had no further treatment yielded a
spread of less than 1.5 x 104 to less than 1.5 x 108 counts per specimen.
The data for the individual specimen is presented in Table II-XVI.
Group B
TABLEII-XVI
Bio-Assay of Group B and C CannedSpecimens
Population
Specimen# Pre-Treatment Post Treatment(Nominal)
ii 106 1.5 x 104
12 106 1.5 x 104
13 108 1.5 x 106
14 108 1.5 x 106
15 109 1.5 x 107
Group C 16 106 1.5 x 104
17 106 1.5 x 104
18 108 1.5 x 107
19 109 1.5 x 107
20 109 1.5 x 108
The remaining Group B and C specimenswere assayed after dry heat treat-
ment and were found to be sterile
The group D specimenswere assayed after steam sterilization and found to
be sterile.
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(2) Demonstration Cycles
(a) Demonstration Cycle #i
Nine test samples, 32 test specimens, and tools and test loads were processed
in the facility as shown in Demonstration Cycle No. I in Appendix C. The
test specimens were in three groups (A, B, and C), each of which contained
specimens with nominal populations of 106 , 108 , and 109 organisms.
At the start of the test, the main chamber was decontaminated by dry heat.
After decontamination of the main chamber, 9 test sample structural
subassemblies and 9 printed circuit boards were placed in the auxiliary
chamber with 9 sterility control specimens. Placement of these items in the
chamber is illustrated in Figure 11-25.
FIGURE II_25
PLACEMENT OF STERILITY CONTROL SPECIMENS
AND TEST SAMPLES IN AUXILIARY CHAMBER
DEMONSTRATION CYCLE NO. I
Rear of Chamber
PCB #91 A-8
SS #54
PCB #I
iss3 ss51tss52j
PCB #5 A-5 PCB #2 A-7 PCB #I01
SS #4
PCB #4ss#iI
A-3
PCB #6
A-I
rn
SS #2
P&B #3
NOTES ;
(2)
Small rectangles represent S/C specimens and large rectangles
represent test samples.
Numbers in small rectangles represent lOgl0 of the nominal
population of the specimens.
(3) Number beside small rectangles give specimen identification.
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(4) Numbersin large rectangles give serial numbers of structural
subassemblies (SS#) and printed circuit Boards (PCB#).
(5) Structural subassemblies I through 5 were innoculated with 108
organisms of B. subtilis var. ni_
Assay of the group A specimens after ETO decontamination showed population
reductions of 4 to 6 logs. The data for the individual specimens is presented
in table II-XVII.
TABLE II-XVII
RESULTS OF BIO-ASSAY OF GROUP A SPECIMENS
DEMONSTRATION CYCLE NO. i
SPECIMEN POPULATION
SPECIMEN # PRETREATMENT POST-TREATMENT
(Nominal)
A-I 108 200
A-2 109 350
A-3 109 20
A-4 106 I0
A-5 108 5
A-6 109 7
A-7 106 6
A-8 106 25
A-9 108 40
In addition to the post-treatment counts shown in tablell-XVll some of the
plates contained colonies morphologically similar to A. niger. This
organism is being used in large quantity in the bio laboratory in performance
on contract NAS 1-6537 (BISS).
Prior to the ETO treatment, 18 sterility control specimens (Group B with
the populations of 106 on 5 specimens, 108 on 7 specimens and 109 on 6
specimens) and 2 thermocouple strips (with 108 populations) were placed
in the auxiliary chamber in a closed container. After the ETO treatment,
they were transferred to the main chamber, removed from their container and
placed on the main chamber grid. Nine were bio-assayed after dry heat steril-
ization. The remaining 9 plus the 2 thermocouple strips were assayed after
the assembly and life test on the test samples. All specimens were found
to be sterile.
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After the life test, the test samples, with the exception of SS #_5-PCB#7
were cut up and bio-assayed. All assayed samples were found to be sterile.
(Because the assay procedure for test samples is destructive, one test sample
was exempted from assay to permit accumulation of a small group of intact,
processed demonstration test samples).
The 5 B. stearothermophilus control specimens of group C (With population
of 106 for 2, I0 _ for 2, and 109 for i) which were autoclaved with the
final bio-assay material were all found to be sterile.
(b) DEMONSTRATION CYCLE NO. 2
Eight test samples, 23 test specimens, and tools and test leads were pro-
cessed in the facility as shown in revised Demonstration Cycle No. 2 in
Appendix C hereto.
The test specimens were in four groups (A, B, C, and D), each of which con-
tained specimens with nominal populations of 106 , 108 , and 109 organisms.
At the start of the test, the main chamber was decontaminated by dry heat.
After decontamination of the main chamber, 8 test sample structural sub-
assemblies and 8 printed circuit boards were placed in the auxiliary chamber
in conjunction with 8 sterility control specimens. Placement of these items
in the chamber is illustrated in Figure ZI-26.
FIGURE II-26
PLACEMENT OF STERILITY CONTROL SPECIMENS AND
TEST SAMPLES IN THE AUXILIARY CHAMBER
DEMONSTRATION CYCLE NO. 2
Rear of Chamber
[_ c-7 _ c-8
17-1
SS #38
PCB #44
SS #37
PCB #40
SS #Ii
PCB #43
SS #8 IPCB #41
SS #I0
PCB #39
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FIGURE 11-26 (Cont'd)
SS #7
PCB #37
[] A-4
A-2
SS #6
PCB #36
A-3
[]A-I
NOTES: (I) Notes (I) through (4) of Figure ll-25apply here also.
(2) Structural subassemblies 6, 7, 9, and I0 were innoculated with
108 organisms of B. subtilis var. n__er.
Assay of the group A specimens after ETO decontamination showed population
reductions of 4 to 6 decades.
The data for the individual specimens is presented in Gable II-XVIII.
TABLE II_XVIII
RESULTS OF BIO-ASSAY OF GROUP A SPECIMENS
DEMONSTRATION CYCLE NO. 2
SPECIMEN #
A-I
SPECIMEN POPULATION
PRE-TREATMENT POST-TREATMENT
(Nominal)
10 6 15
A-2 108 140
A-3 108 88
A-4 109 186
Prior to the ETO treatment, 8 sterility control specimens (Group B with
populations of 106 on 4 specimens, I0 _ on 2 specimens, and I0 _ on 2 speci-
mens) and two thermocouple strips (with 108 populations) were placed in
the auxiliary chamber in a closed container. After the ETO treatment, they
were transferred to the main chamber, removed from their container, and
placed on the main chamber grid. Four were assayed after dry heat sterili-
zation along with the four specimens in Group C. The remaining four, plus
the 2 thermocouple strips, were assayed after the assembly, simulated repair,
and life test of the test samples. All specimens were found to be sterile.
After the life test, the eight test samples were cut up and bio-assayed.
All were found to be sterile.
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The 5 B. stearothermophilus control specimensof group D (with populations of
106 on 2, I0 _ on 2, and IT on i) which were autoclaved with the final bio-
assay material were all found to be sterile.
(c) DEMONSTRATIONCYCLENO. 3
Fourteen test samples, 49 test specimens, five containers, and tools and
test leads were processed in the facility as shownin Appendix C hereto.
The test specimenswere in three groups (A, B, and C) each of which
contained specimenswith nominal populations of l0 b, 108, and 109
organisms.
At the start of the test, the main chamberwas decontaminated by dry
heat. After decontamination of the main chamber, 14 test sample
structural subassemblies and 14 printed circuit boards were placed in
the auxiliary chamberwith 14 sterility control specimens. Placement
of these items in the chamber is illustr_ted in Figure 11-27
FIGURE11-27
PLACEMENTOFSTERILITYCONTROLSPECIMENSANDTEST
SAMPLESIN THEAUXILIARYCHAMBER
DEMONSTRATIONCYCLENO. 3
Rear of Chamber
ss#18I
PCB #461
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PCB #47
SS #12PCB #II
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Bottom Shelf
Rear of Chamber
SS # 49 ] SS # 50
PCB # 531 PCB # 54
SS # 43
PCB #49 SS461LSS47PCB # 50 PCB #52
NOTES : (I) Notes (i) through (4) of Figure 11-25 apply here also.
(2) Structural subassemblies812 through 18 and subassembly 40
were innoculated with I0 organisms of B. subtilis var.
Assay of the group A specimens after ETO decontamination showed popu-
lation reductions of 3 to 6decades_.The data for the individual specimens
is presented in Table II-XIX.
TABLE'_-XIX
RESULTS OF BIO-ASSAY OF GROUP A SPECIMENS
DEMONSTRATION CYCLE NO. 3
SPECIMEN POPULATION
SPECIMEN # PRE-TREATMENT POST-TREATMENT
(Nominal)
A-I 109 < 150
A-2 106 _ 210
A-3 106 _ 30
A-4 109 < 30
A-5 108 _ i00
A-6 108 < i00
A-7 108 < I00
A-8 108 _ 30
A-9 108 _ 300
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SPECIMENPOPULATION
SPECIMEN# PRE-TREATMENT POST-TREATMENT
(Nominal)
A-IO 108 _ 300
A-f1 109 _ 300
A-12 106 ( 300
A-13 106 ( ,300
A-14 106 _ 500
Prior to the ETO treatment, 28 steriltM control specimens, (Group B with
population of 106 on I0 specimens, 108 on 12 @pecimens, and 109 on 6
specimens) and 2 thermocouple strips (with 108 populations) were placed
in the auxiliary chamber in a closed container. After the ETO treat-
ment, they were transferred to the main chamber, removed from their
container and placed on the main chamber grid. Fourteen of these were
assayed after dry heat sterilization. The remaining 14 plus the 2
thermocouple strips were assayed after the assembly and llfe test
of the test samples. All specimens were found to be sterile.
After the life test, 5 of the test samples were sealed in sterile con-
tainers to be recycled in Demonstration No. 4. These were:
(i) SS #13, PCB #17
(2) SS #14, PCB #13
(3) SS #15, PCB #47
(4) SS #43, PCB #49
(5) SS #46, PCB #50
The remaining test samples, with the exception of SS #50 - PCB #54 were
cut up and bio-assayed. All assayed samples were found to be sterile.
(Because the assay procedure for test samples is destructive, one test
sample was exempted from assay to permit accumulation of a small group
of intact, processed demonstration test samples).
The five B. stearothermophilus control specimens of Group C (with popu-
lations of i0 _ on 2, i0 _ on 2, and 109 on i) Which were autoclaved with
the final bio-assay material were all found to be sterile.
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(d) DEMONSTRATION CYCLE NO. 4
Ten test samples, 32 test specimens, and tools and test leads were
processed in the facility as shown in the revised Demonstration Cycle
No. 4 in Appendix C hereto. The test specimens were in five groups,
(A, B, C, D, and E) each of which contained specimens with nominal
populations of 106 , I0 _, and 109 organisms.
At the start of the test, the test chamber was decontaminated by dry
heat. After decontamination of the main chamber, 5 test sample struc-
tural subassemblies and 5 printed circuit boards were placed in the
auxiliary chamber with ten sterility control specimens. Placement of
these items in the chamber is illustrated in Figure 11-28
FIGUREII-28
PLACEMENT OF STERILITY CONTROL SPECIMENS
AND TEST SAMPLES IN THE AUXILIARY
CHAMBER
DEMONSTRATION CYCLE NO. 4
Rear of Chamber
C-6 _ C-7
9 C-10
i#i c. i#iPCB # 35 PCB # 55
SS # 26
PCB # 34]
[SS # 19 ] 9A-56A-4 ISS # 20 [
[PCB # 15 8 A-3 PCB # 16
_A-I _ A-2
NOTES: (I) Notes (I) through (4) of Figure 11-25 apply here also.
(2) Structural subassemblies 19 and 26 wereinoculated with
108 organisms of B. subtills var. niger.
Assay of the group A specimens after ETO decontamination showed popu-
lation reductions of 3 to 5 decades. The data for the individual speci-
mens is presented in Table II-XX.
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TABLE _I-XX
RESULTS OF BIO-ASSAY OF GROUP A SPECIMENS
DEMONSTRATION CYCLE NO. 4
SPECIMEN.POPULATION
SPECIMEN # PRE-TREATMENT POST-TREATMENT
(Nominal)
A-I 108 < 300
A-2 106 ( 30
A-3 108 _600
A-4 106 < 300
A-5 109 _000
Prior to the ETO cycle, i0 sterility control specimens (Group B with
populations of 106 on 4 specimens, 108 on 4 specimens, and 109 on 2
specimens) and two thermocouple strips (with i0 _ populations) were
placed in the auxiliary chamber in a closed container. After the ETO
cycle, they were transferred to the main chamber, removed from their
container and placed on the main chamber grid. Five were assayed
after dry heat sterilization along with the five specimens in Group C.
The remaining five specimens from Group B, the five from Group E and
the 2 thermocouple strips were assayed after the assembly simulated
repair, and life test of the test samples. All specimens were found
to be sterile.
After sterilization of the five test samples in the main chamber, five
samples from cycle No. 3 were introduced in sterile containers through
the autoclave. The intent was to sterilize only the outside surfaces
of the containers. Five B. stearothemophilus sterility control specimens
(group D) were simultaneo_ly introduced through the autoclave in
similar containers as a control to assure that container contents were
not sterilized during container outer surface sterilization.
After the life test, eight of the ten test samples were cut up and
assayed (four from each of the two groups of samples processed).
All were found to be sterile. (The remaining two samples, SS #19 -
PCB #17, and SS #13 - PCB #15 were retained intact.
After all other material had been removed from the analog, the five
specimens of group D were removed from their containers and assayed.
This assayshowed population reductions of less than two logs on 4
of the 5 specimens. Thus, the sterility indicated by the assay of
the recycled test samples is properly interpreted as indicative of
maintaining sterility on these samples during recycllng, which is the
desired result. The data from the individual specimens of Group D is
presented in _sble II-XXI.
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TABLEII.-XXI
RESULTS OF BIO-ASSAY OF GROUP D SPECIMENS
DEMONSTRATION CYCLE No. 4
SPECIMEN # PRE-TREATMENT POST-TREATMENT POPULATIONS
NON-HEAT SHOCKED HEAT SHOCKED
D-I 106 1.3 X 104 Ioi X 104
D-2 106 3.7 X 104 3.7 X 104
D-3 I08 2.0 X 106 1.7 X 104
D-4 108 4.9 X 104 4.4 X l06
D-5 109 < 5 X I05 _ 5 X I05
(e) DEMONSTRATION CYCLE NO. 5
Nine test samples, 32 test specimens, and tools and test leads were pro-
cessed in the facility as shown in the revised Demonstration Cycle No. 5
in Appendix C hereto (this is the same as cycle No. i). The specimens
were in three groups (A, B, and C) each of which contained specimens with
nominal populations of 106 , 108 , and 109 organisms.
At the start of the test, the main chamber was decontaminated by dry
heat. After decontamination of the main chamber, 9 test sample struc-
tural assemblies and 9 printed circuit boards were placed in the auxiliary
chamber with 9 sterility control specimens. Placement of these items in
the chamber is illustreted in Figure 11-29.
FIGURE II- 29
PLACEMENT OF STERILITY CONTROL SPECIMENS AND
TEST SAMPLES IN THE AUXILIARY CHAMBER
DEMONSTRATION CYCLE NO. 5
IPCB # 31] PCB #32
SS #25" I SS # 31 1PCB #28 PCB #29
A-4
iSS #22, I SS #23"
i SS #35 1PCB #33
I SS #32PCB #30
SS #24PCB #27
Front of Chamber
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NOTES: (I) Notes (i) through (4) of Figure 11-25 apply here also.
(2) Structural subassemblies 22, 23, and 25 were innoculated
with 108 organisms of B. subtilis var. niger.
Assay of the group A specimens after ETO decontamination showed population
reductions of 3 to 5 decades. The data for the individu_l specimens are
presented in table II-XXII.
TABLE II-_XII
RESULTS OF BIO-ASSAY OF GROUP A SPECIMENS
DEMONSTRATION CYCLE NO. 5
SPECIMEN POPULATION
SPECIMEN # PRE-TREATMENT POST-TREATMENT
(Nominal)
A-I 106 _ 1500
A-2 i08 _ 1500
A-3 109 < 1500
A-4 106 _ 1500
A-5 108 < 1500
A-6 109 _ 1500
A-7 106 < 1500
A-8 108 < 1500
A-9 109 _1500
Prior to the ETO cycle_ 18 sterility control specimens (Group B with
populations of 106 , I08, and 109 on each of three subgroups of 6
specimens) and 2 thermocouple strips (with populations of 108 ) were
placed in the auxiliary chamber in a closed container. After the ETO
cycle, they were transferred to the main chamber, removed from their con-
tainer, and placed on the main chamber grid. Nine were bio-assayed
after dry heat sterilization. The remaining 9 plus the two thermocouple
strips were assayed after the assembly and life test on the test samples.
All specimens were found to be sterile.
After the life test, the test samples, with the exception of SS #31 -
PCB #33 were cut up and assayed. All assayed samples were found to be
sterile. (Because the assay procedure for test samples is destructive,
one test sample was exempted from assay to permit accumulation of a
small group of intact, processed demonstration test samples).
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(f) AIR SAMPLINGDURINGDEMONSTRATIONCYCLES
Air samples were taken in the horizontal laminar flow clean room during
demonstration cycles I through 5 for a total of 48 samples. _enty-
four (24) samples were taken upstream of the analog, and twenty-four
(24) samples were taken downstreamof the analog. The results of
this 6ampling are summarized in Tablell-XXlll. The highest count from the
48 samples was 2.5 counts/ft3.
TABLE II-XXIII
AIR SAMPLING RESULTS SUMMARY
POPULATION DENSITY RANGE
(c-_unts/ft_---- Upstream Downstream
.01 to .05 15 5
.05 + to .I0 4 5
.I0 + to .50 3 Ii
.50 + to 1.0 I 3
Greater than 1.0 I 0
TOTAL 24 24
Average Population density for 24 Counts : Upstream .181 (counts/ft3)
: Downstream .239 " "
Average Population density for 48 Counts : Combined .210 " "
FRE__UENCY OF OCCURANCE
The data for the individual air samples is presented in Table II_(XTV
Combined
20
9
14
4
i
48
CYCLE #
TABLE II-MXIV
AIR SAMPLING BIO-ASSAY DATA FOR DEMONSTRATION
CYCLES # 1-5
TIME INTO CYCLE
(0 time is at start
of heat decontamination
of main chamber) Upstream
+ 20 hrs. 0.05
+ 39 hrs. 0.03
+ 46 hrs. 2.5
ORGANISM DENSITY
(Counts/ft3)
Downstream
0.08
0.I
0.08
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TABLEII-XXIV (Continued)
CYCLE# TIME INTOCYCLE
2
4
- I0 hrs.
+ 15 hrs.
+ 20 hrs.
+ 39 hrs.
+ 66 hrs.
- 6 hrs.
+ 17hrs.
+ 69 hrs.
+ 96 hrs.
- 4 hrs.
+ 16 hrs.
+ 33 hrs.
+ 40 hrs.
+ 69 hrs.
+ 95 hrs.
- 137 hrs.
- 87 hrs.
+ 28 hrs.
+ 55 hrs.
+ 77 hrs.
+ I00 hrs.
POPULATIONDENSITY
Upstream
0.03
0.08
0.03
0.05
0.I
Downstream
0.37
0.67
0.3
0.25
0.45
0.03
0.17
0.12
0.03
0.43
0.58
0.23
0.07
0.08
0.02
0.03
0.02
0.02
0.02
0.23
0.13
0.03
0.03
0.03
0.13
0.03
0.05
0.65
0.12
0.06
0.03
0.05
0.03
0.75
0.37
0.25
0.I0
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FIGURE11-30
PLACEMENTOFAIR SAMPLERSANDFALLOUTSTRIPS
IN THECLEAN ROOM
@@@
Cabinet
(downstream trays on top)
I
downs tream
Reynier
sampler
Raynler
Sampler
Air flow
Analog
(Upstream trays on top)
@ ®
The samples were taken using Reynler samplers. One sampler was placed three
feet above the floor at a point just upstream in the clean room from the
analog, and another was placed three feet above the floor at a point near
the downstream end of the room (See Figurell-30_The plates were incubated for
3 days and the number of viable counts per cubic foot of air was computed.
9. FALLOUT SAMPLING DURING DEMONSTRATION CYCLES
Six trays of one by two inch stainless steel fallout strips were placed in the
laminar flow clean room as shown in figure 11-30 (three trays upstream & 3 trays
downstream). During cycle No. I one strip was removed from each tray and
assayed. The remaining strips were sterilized and returned to the sampling
sites where they remained throughout the rest of the test program.
Once per week during cycles 2 through 4, twice during the week preceedlng cycle
5 and four times during cycle 5, one strip was removed from each tray and
assayed. The maximum, minimum, and average counts/ft 3 were computed for the
upstream and downstream sampling sites for each sampling time. The data from
this sampling is presented in table II4LXV. These data are so widely spread
that no pattern is evident. Larger sample quantities would have to be
taken at much more frequent intervals to develop a pattern of accumulation
and die off.
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D. TASK 4. FULL SCALE FACILITY DESIGN STUDY
This task involved the performance of a preliminary design study on a full
scale facility for processing of sterile flight vehicles using the
Assembly/Sterilizer concept. The primary purpose of the study was to
ascertain whether the design and construction of such a facility is feasible.
The complete study results are contained in Appendix E. This appendix
summarizes the study, defines the facility concepts (with recommendation
of the perferred concept), presents the results of the design analyses
performed, and provides estimates of costs and schedules for the design
and construction of the recommended facility.
The analysis portion in the study centered on the major design problem:
a practical design for 400,000 cubic foot sealed vessel which operate s at
temperatures of 75 ° F to 300°F. A practical structual concept has been
defined and the magnitude of the associated thermal design problem has been
identified. More detailed study is needed in the thermal design area but
was beyond the scope of the study.
The overall conclusion from the study is that the final design and con-
struction appears technically and economically feasible. Though further
studies are necessary to reinforce this conclusion and to provide a firmer
basis for cost and schedule estimates, all investigations to date have
had positive results.
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III. ASSEMBLY/STERILIZERANALOG
The Assembly/Sterilizer Analog provides a small scale simulation of the
Assembly/Sterilizer. The Analog requirements were defined by G.E. and the
equipment was designed and fabricated by KewauneeScientific Equipment.
The Assembly/Sterilizer Analog consists of three chambers- a main chamber, _n
auxiliary chamber, and an autoclave chamber. The main and auxiliary chambers
are controlled dry sterilizers and the autoclave is a steam sterilizer. The
main and auxiliary chambersare capable of using either nitrogen or air as the
recirculating gas, and the auxiliary chamber is also capable of h_ndling
ethylene oxide/FREON-12(ETO/FREON).
Primary sterilization is to be performed by recirculating dry heated sterile
nitrogen, at less than 1%relative humidity within the main chamber, using the
laminar flow principle and maintaining positive pressure within the chamberat
all times. Although nitrogen is the gas intended for normal use, the A/S
Analog is compatible with the use of other gases such as ethylene oxide,
heliu_ and freon. (Although the present main chamberblower will not handle
a gas of the density of ETO/FREON,a suitable blower is on hand and can be
installed.)
In addition, the auxiliary chamberand autoclave are used to sterilize compo-
nents which are introduced into the sterile main chamberafter the primary
sterilization cycle has been completed.
An artist's conception of the Assembly/Sterilizer Analog is shownin Figure
III-I. This drawing shows the spatial interrelations of the several portions
of the system. Photographs of the completed Analog are shownin Figures 11-12
throughll-15.
The operating temperature of the main chamber is controllable from 70°F. to
300°F., and the operating temperature range of the auxiliary chamber is control-
lable from 100OF. to 300°F. The relative humidity in the chambers is control-
lable from 20%to 60%from 70°F. to 90OF, and at less than 1%from 200°F. to
300°F. WhenETOis the recirculating gas, the temperature is controllable
between 100°F. and 150°F. at a relative humidity of 50%to 60%. At no time
will the relative humidity within either chamberexceed 60%. The temperature
rate of change on heat-up or cool-down is 25°F. to 50°F. per hour for both
chambers.-
A flash heat exchanger to vaporize the Ethylene-Oxide Freon (ETO) used in the
system is provided. A set of 650°F., 1.5 second, incinerators is also provided
to sterilize the Nitrogen used in the system.
The main chamber is constructed of welded 304 stainless steel. The nominal
inside working dimensions are 60" long x 24" deep x 30" high.
Access panels to the inside of the main chamberare located on both ends of
the enclosure. The dimensions of the panels permit a 16" diameter disc to
pass through the plane of the opening. These are bolt on service panels and
are not used during routine operation of the Analog.
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Figure lll-I o AssemblylSterilizer Analo 8
A large sloping observation window made from heat resistant, shatterproof,
glass plate is provided on the front of the main chamber. To aid in the
retention of heat during the sterilization cycle, a removable cover is used
over the window. Two 8" ports, suitable for observation of the interior of
the chamber, are incorporated in the cover.
Interconnected electrical junction panels with ten terminals each are located
inside and outside the main chamber on the back surface. The terminals pro-
vide for banana plug and stripped wire connections between the inside and out-
side of the chamber.
Twenty permanent-type sheathed thermocouples are provided inside the chamber.
Two se_ of gloves are provided on the front p_nel of the chamber. The gloves
are made of 30 mil sulfur-free butyl rubber giving a glove which is soft,
pliable, leakproof, and is capable of repeated exposure to all the environ-
ments specified for the equipment.
The chamber is capable of being purged with dry nitrogen until essenti_lly _II
of the air is removed. (Approximately 20 volume changes per hour.) Flow rate
meters are provided. Provision is incorporated for biological assay of the
main chamber atmospheres.
The chamber is capable of continuous recirculation of the gas at a preselected
velocity while maintaining the chamber in accordance with the environments
specified. The makeup nitrogen gas is incinerated prior to entrance to the
main chamber.
Two filters are provided in the design of the main chamber. One, a prefilter,
is located in the floor of the chamber and the other, a final filter, is
located in the top of the chamber. Both filters are removable for cleaning or
replacement without disassembly of the chamber. The filters are such that the
gas-borne particle count within the chamber will not exceed a total of I00
particles per cubic foot of 0.5 microns and larger. The floor of the main
chamber is a grating with openings of one-half inch by one inch.
The auxiliary and autoclave chambers are attached to the back of the main
chamber. The design of the doors between the auxiliary and autoclave chambers
and the main chamber is such that the doors can be readily opened with a
gloved hand. The doors open and slide in a horizontal plane.
The A/S Analog is so designed that the outside surface temperature of the
chamber does not exceed 100°F. at any operating temperature and an ambient
temperature of 70°F. to 80°F.
The main chamber maintains a controllable pressure gradient of up to 4" of
water. The chamber does not exhibit any leak detectable with a helium mass
spectrometer.
The auxiliary chamber design and construction is similar to the main chamber,
except that the approximate size is I0" square x 16" long. The access door to
the auxiliary chamber is located on the back of the chamber and permits com-
plete uninhibited access to the chamber. Shelves are provided so that work
pieces may be withdrawn. The shelves are capable of being withdrawn either
into the main chamber from the front or out of the auxiliary chamber from the
back.
77
Six sheathed thermocouples are provided and are of sufficient length to sllow
the thermocouples to be disconnected from the chambercontents with the gloved
hand when the shelves are withdrawn into the main chamber. The chamber is
capable of being purged with dry nitrogen until essentially all of the air is
removed. (Approximately 20 volume changesper hour.) Flow rate meters are
provided.
The auxiliary chamber is capable of recirculating the gas in a path independent
of the main chamberbut is not laminar flow. Onefilter is provided in the
design of the auxiliary chamberand is capable of being removedfor cleaning
or replacement without disassembly of the chamber.
The outside surface of the auxiliary chamberdoes not exceed 100°F. at any
operating temperature and an ambient temperature of 70°F. to 80°F. The aux-
iliary chambermaintains a controllable pressure gradient of up to 4" of
water. The chamberdoes not exhibit any leak detectable with a helium mass
spectrometer.
The autoclave chamber is a horizontal, vacuumpressure type vessel of approxi-
mately 18" diameter x 26" long, designed for operating pressures up to 30 psig.
All details of design, materials and construction meet or exceed the require-
ment of the American Society of Mechanical Engineers code for unfired pressure
vessels. The chamber is of welded 304 stainless steel.
The access door to the autoclave chamberis located on the back of the chamber
and is of such a size as to permit uninhibited access to the chamber. The
door is of the radial locking arm type. Shelves are provided inside the
chamber to permit the work pieces to be withdrawn.
Six sheathed thermocouples are provided and are of sufficient length to allow
the thermocouples to be disconnected from the autoclave contents with the
gloved hand when the shelves are withdrawn into the main chamber.
The autoclave chamber is capable of being purged with dry nitrogen. (Approxi-
mately 20 colume changes per hour.) After the cooling cycle, and during
purging, the autoclave will maintain a positive pressure relative to ambient.
The rate of steam admission is such that the autoclave chamberpressure can be
raised to 30 psig in five minutes with an empty chamber.
The control console contains the instruments and circuitry for controlling the
Analog. The following table identifies the instruments and their functions.
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TABLEIII-I. ANALOGCONTROL CONSOLE INSTRUMENTS (Note I)
INSTRUMENT FUNCTION
Temperature Controller/Recorder i° Control and record main
chamber gas temperatures.
2. Control and record auxiliary
chamber gas temperatures.
Recorder 24 Channel Multipanel Record skin temperatures and
relative humidities of main
and auxiliary chambers.
Meter/Relay Temperature
Controllers (6)
I. Main chamber oven temperature.
2. Auxiliary chamber oven
temperature.
3. Main chamber N 2 incinerator.
4. Auxiliary chamber N 2 incinarator.
5. ETO heat exchanger.
6. Autoclave N 2 incinerator.
Pressure Recorder (3 channel) Record gas pressure in Analog
chambers.
Differential Temperature
Controllers (7)
Slave Analog skin temperatures
to gas temperature.
RH Controllers Control RH in main and
auxiliary chambers.
Timers (3) I. Time autoclave gas plumbing
sterilization.
2. Relay main chamber incinerators
while pumping ETO out of
chamber.
3. Relay auximilary chamber incin-
erators while pumping ETO out
of chamber.
Flow Meters (7) Measure supply gas flows to
Analog and RH sample gas flows.
Note I. The autoclave steam cycle controls are located on the autoclave rather
than on the console.
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IV. RECOMMENDATIONS
The success of the present program suggests that the overall recon_nendation
be that the Assembly/Sterilizer be considered as an economically and tech-
nically feasible facility for processing sterile interplanetary flight veh-
icles. It is recognized that feasibility has been more inferred than proven
on the program. But viewing the weight of the results in light of the limited
fiscal and work statement scope of the program, the inference is most strong.
Before any new facility of the complexity and sophistication of the Assembly/
Sterilizer can be endorsed without qualification, investigation beyond the
scope of the present contract studies is needed. The following recormnended
investigations are regarded as those which should removeany reservation as
to the feasibility of the facility.
Perform a thermal analysis of the Assembly/Sterilizer facility
in sufficient detail to size heat exchangers and wall modules,
and design and analyze a thermal control system in sufficient
depth to identify the types and numbersof all elements of the
system.
Review the concept of the use of vertical laminar flow in the
Assembly/Sterilizer to trade-off the improvement it offers in
physical and biological cleanliness of the chamber environment
before sealing-off against the complexity it adds to the struct-
ure, thermal control system, and gas movementsystem.
Investigate door and window openings to select optimumcon-
figurations. In particular, examinewindow and door thermal
design problems, door seals, door supports, and door latching
mechanisms.
Investigate bio-confidence monitoring systems based on physical
measurementson the chambersor their contained gases. In
particular investigate the use of gas leak detection techniques
in terms of sensitivity, cost, and confidence enhancement.
Perform a gas managementstudy to define the sizes and quantities
of storage facilities, plumbing, and gas processing units. One
area in particular that deserves further study is the design of an
on-site facility for mixing and processing ethylene oxide and
FREON-12to achieve the desired concentrations in the chambers.
Gas reclamation systems should be examined to permit an accurate
gas economics analysis.
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Design and construct a room size model of the Assembly/Sterilizer for
testing the Bio-lsolator Suit System and the chamber control systems.
Such a facility would verify by experimentation the validity of the
design analyses on nmjor portions of the full scale facillty and
would provide a facility for processing small flight vehicles.
In addition to the above reconznendations directed at improving the confidence
in assertions of feasibility of the facility, the followlng studies would
enhance the contribution the Assembly/Sterillzer will make to interplanetary
programs.
Perform a work flow analysis on the mast current Voyager design
definition to optimize the facility fo_ processlgn the flight
hardware. This analysis is necessary to permit improved evalua-
tion of the sizing of the chambers and support areas of the
facility, the flow within the facility, and the operating modes
of the facility chambers (eg. final decision on use of ET0/FREON
in Assembly/Sterillzer main chamber.)
Investigate the long range interplanetary programs projections
to determine the applicability of the Assembly/Sterillzer to
program after Voyager.
Finally, it is recommended that the Assembly/Sterillzer Analog be seriously
considered in planning and experimental efforts directed at the determination
of the total physical and biological effects of dry heat sterilization of can-
didate materlalsp parts, components, and small assemblies for sterile flight
vehicles. The analog is the only exlstant facility which permits physical
and electrical access to decontaminated and sterilized equipment without the
access provisions altering the biological environment; which permits true
sterile insertion; and which permits performance of biological assays under
sterile conditions.
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